Corton Capital Inc. Biogen Inc. Transaction History

Corton Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $158,261 - $190,505	711 Added 56.12%	1,978 $511,000
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $320,931 - $362,222	1,267 New	1,267 $325,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $68,725 - $94,766	-353 Reduced 22.06%	1,247 $333,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $266,306 - $316,688	-1,420 Reduced 47.02%	1,600 $326,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $585,185 - $737,302	3,020 New	3,020 $636,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.